Showing results (2311-2320 of 3,010) with videos related to

Sort By:
Pageof 301
Pediatric Research|June 27, 2002
Predictors of 30-month outcome after perinatal depression: role of proton MRS and socioeconomic factorsSteven P Miller, Nancy Newton, Donna M Ferriero, et al.
International Journal of Molecular Sciences|January 27, 2019
Post-Injury Neuroprotective Effects of the Thalidomide Analog 3,6'-Dithiothalidomide on Traumatic Brain InjuryBuyandelger Batsaikhan, Jing-Ya Wang, Michael T Scerba, et al.
Plos Genetics|October 5, 2019
Kinetochore-associated Stu2 promotes chromosome biorientation in vivoMatthew P Miller, Rena K Evans, Alex Zelter, et al.
Globalization and Health|September 4, 2021
Global health classroom: mixed methods evaluation of an interinstitutional model for reciprocal global health learning among Samoan and New Zealand medical studentsRoshit K Bothara, Malama Tafuna'i, Tim J Wilkinson, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 13, 2021
Kinetic analysis and optimisation of 18F-rhPSMA-7.3 PET imaging of prostate cancerSimona Malaspina, Vesa Oikonen, Anna Kuisma, et al.
Diabetes|June 26, 2001
Improved glucose tolerance and acinar dysmorphogenesis by targeted expression of transcription factor PDX-1 to the exocrine pancreasR S Heller, D A Stoffers, T Bock, et al.
Biological Psychiatry|May 10, 2001
Brain structure, genetic liability, and psychotic symptoms in subjects at high risk of developing schizophreniaS M Lawrie, H C Whalley, S S Abukmeil, et al.
The American Journal of Cardiology|February 25, 1991
Electrocardiographic subset analysis of diltiazem administration on long-term outcome after acute myocardial infarction. The Multicenter Diltiazem Post-Infarction Trial Research GroupW E Boden, R J Krone, R E Kleiger, et al.
Environmental Science & Technology|December 31, 2009
Dissolved organic matter sources and consequences for iron and arsenic mobilization in Bangladesh aquifersNatalie Mladenov, Yan Zheng, Matthew P Miller, et al.
Leukemia & Lymphoma|April 18, 2009
A phase II trial of single agent bevacizumab in patients with relapsed, aggressive non-Hodgkin lymphoma: Southwest oncology group study S0108Alison T Stopeck, Joseph M Unger, Lisa M Rimsza, et al.
Pageof 301